A recent medicines recall has highlighted the critical role pharmacy teams play in safeguarding patients, after a patient complaint about headaches led to the discovery of a dispensing issue involving antidepressants.
The incident centred on a batch of sertraline 100mg tablets, which was recalled after it was identified that some packs contained the wrong medication. A patient reporting unexpected symptoms prompted further investigation, ultimately triggering the recall.
The issue arose after reports that cartons labelled as sertraline contained blister strips of a different antidepressant, citalopram. While both medicines belong to the same class, selective serotonin reuptake inhibitors, they are prescribed differently and at varying doses. An unintended switch between antidepressants can lead to adverse effects, changes in symptom control, and confusion for patients.
In this case, it was a patient experiencing unexpected headaches that raised concerns and led to the issue being identified. Symptoms such as headaches, nausea, sleep disturbances and increased anxiety are not uncommon when starting or switching antidepressants, but any unexpected change should always be explored.
This situation reinforces the importance of robust checking procedures at every stage of the dispensing process. Pharmacy teams are often the final point of contact before a medicine reaches the patient, and while manufacturer errors are rare, they do occur. The ability to identify discrepancies quickly can significantly reduce patient risk.
There are several practical steps pharmacy teams can continue to prioritise in day to day practice. Careful visual checks of packaging and blister contents remain essential, particularly where medicines may appear similar. Encouraging patients to report unusual symptoms or concerns is equally important, as is responding promptly to queries, even when symptoms initially appear minor. Staying up to date with MHRA alerts and acting quickly on recall notifications also remains a key part of maintaining patient safety.
Medicines recalls form part of routine quality assurance across the supply chain, but their effectiveness relies on swift and consistent action at pharmacy level. Systems should be in place to ensure alerts are reviewed, communicated to the team, and acted upon within the required timeframes.
One of the most important takeaways from this case is the value of patient engagement. Patients are often the first to notice when something does not feel right, and creating an environment where they feel comfortable raising concerns can make a meaningful difference. Taking those concerns seriously, regardless of how minor they may seem, can help identify issues early and prevent harm.
Pharmacy teams should continue to reassure patients while investigating concerns, provide clear guidance on what to do if medication appears different, and escalate issues appropriately where needed.
While recalls involving incorrect medicines are uncommon, they highlight how easily errors can occur within complex supply chains. For pharmacy teams, this serves as a timely reminder to remain vigilant, particularly when handling high volume or commonly prescribed medicines such as antidepressants.
Simple checks, strong processes and proactive communication remain at the heart of safe and effective pharmacy practice, and as this case demonstrates, even a single patient query can play a crucial role in protecting wider patient safety.